Literature DB >> 16684809

The role of vitamin D in multiple sclerosis.

Sherrill J Brown1.   

Abstract

OBJECTIVE: To evaluate the literature about the role of vitamin D in the prevention and treatment of multiple sclerosis (MS). DATA SOURCES: MEDLINE (1966-April 2006) and International Pharmaceutical Abstracts (1970-April 2006) searches were performed. In addition, pertinent references from identified articles were obtained. Key search terms included vitamin D, 25-hydroxyvitamin D, vitamin D deficiency, and multiple sclerosis. DATA SYNTHESIS: Vitamin D supplementation prevented the development and progression of experimental autoimmune encephalitis, an animal model of MS, in mice. A large, prospective, cohort study found that vitamin D supplementation was associated with a 40% reduction in the risk of developing MS. Four small, noncontrolled studies suggested that vitamin D supplementation may decrease exacerbation of MS symptoms.
CONCLUSIONS: Vitamin D supplementation may help prevent the development of MS and may be a useful addition to therapy. However, current studies are in small populations and are confounded by other variables, such as additional vitamin and mineral supplementation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16684809     DOI: 10.1345/aph.1G513

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  15 in total

Review 1.  Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada (summary).

Authors:  David A Hanley; Ann Cranney; Glenville Jones; Susan J Whiting; William D Leslie
Journal:  CMAJ       Date:  2010-07-12       Impact factor: 8.262

Review 2.  Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada.

Authors:  David A Hanley; Ann Cranney; Glenville Jones; Susan J Whiting; William D Leslie; David E C Cole; Stephanie A Atkinson; Robert G Josse; Sidney Feldman; Gregory A Kline; Cheryl Rosen
Journal:  CMAJ       Date:  2010-07-12       Impact factor: 8.262

3.  Alteration of DBP levels in CSF of patients with MS by proteomics analysis.

Authors:  Zhaoyu Qin; Yanjiang Qin; Shilian Liu
Journal:  Cell Mol Neurobiol       Date:  2008-09-19       Impact factor: 5.046

Review 4.  Vitamin D signaling, infectious diseases, and regulation of innate immunity.

Authors:  John H White
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

5.  Serum levels of 25-hydroxy vitamin D in normal Biozzi and C57BL/6 mice and during the course of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).

Authors:  Christopher Bolton; Janet Gates; Gavin Giovannoni
Journal:  Inflamm Res       Date:  2013-04-20       Impact factor: 4.575

Review 6.  Evaluating the Effects of Dietary Interventions on Disease Progression and Symptoms of Adults with Multiple Sclerosis: An Umbrella Review.

Authors:  Abbey R Tredinnick; Yasmine C Probst
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

Review 7.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

8.  Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy.

Authors:  Sina Nettekoven; Alexander Ströhle; Birgit Trunz; Maike Wolters; Susanne Hoffmann; Rüdiger Horn; Martin Steinert; Georg Brabant; Ralf Lichtinghagen; Hans-Jürgen Welkoborsky; Ingrid Tuxhorn; Andreas Hahn
Journal:  Eur J Pediatr       Date:  2008-02-13       Impact factor: 3.183

Review 9.  Clinical implications of a possible role of vitamin D in multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny
Journal:  J Neurol       Date:  2009-04-28       Impact factor: 4.849

10.  Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures.

Authors:  Robert P Lisak; Joyce A Benjamins; Beverly Bealmear; Liljana Nedelkoska; Diane Studzinski; Ernest Retland; Bin Yao; Susan Land
Journal:  J Neuroinflammation       Date:  2009-01-21       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.